Global Severe Asthma Treatment Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Severe Asthma Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Severe Asthma Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Severe Asthma Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Severe Asthma Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Severe Asthma Treatment players cover Teva Pharmaceutical, AstraZeneca, GlaxoSmithKline, Novartis, Sanofi, Regeneron Pharmaceutical, 4D Pharma plc, AB Pharma and Morphosys, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Severe Asthma Treatment Industry Forecast” looks at past sales and reviews total world Severe Asthma Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Severe Asthma Treatment sales for 2023 through 2029. With Severe Asthma Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Severe Asthma Treatment industry.
This Insight Report provides a comprehensive analysis of the global Severe Asthma Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Severe Asthma Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Severe Asthma Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Severe Asthma Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Severe Asthma Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Severe Asthma Treatment market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Severe Asthma Treatment market?
What factors are driving Severe Asthma Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Severe Asthma Treatment market opportunities vary by end market size?
How does Severe Asthma Treatment break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The global Severe Asthma Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Severe Asthma Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Severe Asthma Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Severe Asthma Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Severe Asthma Treatment players cover Teva Pharmaceutical, AstraZeneca, GlaxoSmithKline, Novartis, Sanofi, Regeneron Pharmaceutical, 4D Pharma plc, AB Pharma and Morphosys, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Severe Asthma Treatment Industry Forecast” looks at past sales and reviews total world Severe Asthma Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Severe Asthma Treatment sales for 2023 through 2029. With Severe Asthma Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Severe Asthma Treatment industry.
This Insight Report provides a comprehensive analysis of the global Severe Asthma Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Severe Asthma Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Severe Asthma Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Severe Asthma Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Severe Asthma Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Severe Asthma Treatment market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Oral
- lnhaled
- lntravenous
- Subcutaneous
- Children
- Adults
- Teenagers
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva Pharmaceutical
- AstraZeneca
- GlaxoSmithKline
- Novartis
- Sanofi
- Regeneron Pharmaceutical
- 4D Pharma plc
- AB Pharma
- Morphosys
- Roche
- Avalo Therapeutics
- Suzhou Connect Biopharmaceuticals
- Pieris Pharma
- Biosion
What is the 10-year outlook for the global Severe Asthma Treatment market?
What factors are driving Severe Asthma Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Severe Asthma Treatment market opportunities vary by end market size?
How does Severe Asthma Treatment break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Severe Asthma Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Severe Asthma Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Severe Asthma Treatment by Country/Region, 2018, 2022 & 2029
2.2 Severe Asthma Treatment Segment by Type
2.2.1 Oral
2.2.2 lnhaled
2.2.3 lntravenous
2.2.4 Subcutaneous
2.3 Severe Asthma Treatment Sales by Type
2.3.1 Global Severe Asthma Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Severe Asthma Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Severe Asthma Treatment Sale Price by Type (2018-2023)
2.4 Severe Asthma Treatment Segment by Application
2.4.1 Children
2.4.2 Adults
2.4.3 Teenagers
2.5 Severe Asthma Treatment Sales by Application
2.5.1 Global Severe Asthma Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Severe Asthma Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Severe Asthma Treatment Sale Price by Application (2018-2023)
3 GLOBAL SEVERE ASTHMA TREATMENT BY COMPANY
3.1 Global Severe Asthma Treatment Breakdown Data by Company
3.1.1 Global Severe Asthma Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Severe Asthma Treatment Sales Market Share by Company (2018-2023)
3.2 Global Severe Asthma Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Severe Asthma Treatment Revenue by Company (2018-2023)
3.2.2 Global Severe Asthma Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Severe Asthma Treatment Sale Price by Company
3.4 Key Manufacturers Severe Asthma Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Severe Asthma Treatment Product Location Distribution
3.4.2 Players Severe Asthma Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SEVERE ASTHMA TREATMENT BY GEOGRAPHIC REGION
4.1 World Historic Severe Asthma Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Severe Asthma Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Severe Asthma Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Severe Asthma Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Severe Asthma Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Severe Asthma Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Severe Asthma Treatment Sales Growth
4.4 APAC Severe Asthma Treatment Sales Growth
4.5 Europe Severe Asthma Treatment Sales Growth
4.6 Middle East & Africa Severe Asthma Treatment Sales Growth
5 AMERICAS
5.1 Americas Severe Asthma Treatment Sales by Country
5.1.1 Americas Severe Asthma Treatment Sales by Country (2018-2023)
5.1.2 Americas Severe Asthma Treatment Revenue by Country (2018-2023)
5.2 Americas Severe Asthma Treatment Sales by Type
5.3 Americas Severe Asthma Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Severe Asthma Treatment Sales by Region
6.1.1 APAC Severe Asthma Treatment Sales by Region (2018-2023)
6.1.2 APAC Severe Asthma Treatment Revenue by Region (2018-2023)
6.2 APAC Severe Asthma Treatment Sales by Type
6.3 APAC Severe Asthma Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Severe Asthma Treatment by Country
7.1.1 Europe Severe Asthma Treatment Sales by Country (2018-2023)
7.1.2 Europe Severe Asthma Treatment Revenue by Country (2018-2023)
7.2 Europe Severe Asthma Treatment Sales by Type
7.3 Europe Severe Asthma Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Severe Asthma Treatment by Country
8.1.1 Middle East & Africa Severe Asthma Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Severe Asthma Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Severe Asthma Treatment Sales by Type
8.3 Middle East & Africa Severe Asthma Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Severe Asthma Treatment
10.3 Manufacturing Process Analysis of Severe Asthma Treatment
10.4 Industry Chain Structure of Severe Asthma Treatment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Severe Asthma Treatment Distributors
11.3 Severe Asthma Treatment Customer
12 WORLD FORECAST REVIEW FOR SEVERE ASTHMA TREATMENT BY GEOGRAPHIC REGION
12.1 Global Severe Asthma Treatment Market Size Forecast by Region
12.1.1 Global Severe Asthma Treatment Forecast by Region (2024-2029)
12.1.2 Global Severe Asthma Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Severe Asthma Treatment Forecast by Type
12.7 Global Severe Asthma Treatment Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Teva Pharmaceutical
13.1.1 Teva Pharmaceutical Company Information
13.1.2 Teva Pharmaceutical Severe Asthma Treatment Product Portfolios and Specifications
13.1.3 Teva Pharmaceutical Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Teva Pharmaceutical Main Business Overview
13.1.5 Teva Pharmaceutical Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Severe Asthma Treatment Product Portfolios and Specifications
13.2.3 AstraZeneca Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Severe Asthma Treatment Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Severe Asthma Treatment Product Portfolios and Specifications
13.4.3 Novartis Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Severe Asthma Treatment Product Portfolios and Specifications
13.5.3 Sanofi Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Regeneron Pharmaceutical
13.6.1 Regeneron Pharmaceutical Company Information
13.6.2 Regeneron Pharmaceutical Severe Asthma Treatment Product Portfolios and Specifications
13.6.3 Regeneron Pharmaceutical Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Regeneron Pharmaceutical Main Business Overview
13.6.5 Regeneron Pharmaceutical Latest Developments
13.7 4D Pharma plc
13.7.1 4D Pharma plc Company Information
13.7.2 4D Pharma plc Severe Asthma Treatment Product Portfolios and Specifications
13.7.3 4D Pharma plc Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 4D Pharma plc Main Business Overview
13.7.5 4D Pharma plc Latest Developments
13.8 AB Pharma
13.8.1 AB Pharma Company Information
13.8.2 AB Pharma Severe Asthma Treatment Product Portfolios and Specifications
13.8.3 AB Pharma Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 AB Pharma Main Business Overview
13.8.5 AB Pharma Latest Developments
13.9 Morphosys
13.9.1 Morphosys Company Information
13.9.2 Morphosys Severe Asthma Treatment Product Portfolios and Specifications
13.9.3 Morphosys Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Morphosys Main Business Overview
13.9.5 Morphosys Latest Developments
13.10 Roche
13.10.1 Roche Company Information
13.10.2 Roche Severe Asthma Treatment Product Portfolios and Specifications
13.10.3 Roche Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Roche Main Business Overview
13.10.5 Roche Latest Developments
13.11 Avalo Therapeutics
13.11.1 Avalo Therapeutics Company Information
13.11.2 Avalo Therapeutics Severe Asthma Treatment Product Portfolios and Specifications
13.11.3 Avalo Therapeutics Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Avalo Therapeutics Main Business Overview
13.11.5 Avalo Therapeutics Latest Developments
13.12 Suzhou Connect Biopharmaceuticals
13.12.1 Suzhou Connect Biopharmaceuticals Company Information
13.12.2 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product Portfolios and Specifications
13.12.3 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Suzhou Connect Biopharmaceuticals Main Business Overview
13.12.5 Suzhou Connect Biopharmaceuticals Latest Developments
13.13 Pieris Pharma
13.13.1 Pieris Pharma Company Information
13.13.2 Pieris Pharma Severe Asthma Treatment Product Portfolios and Specifications
13.13.3 Pieris Pharma Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Pieris Pharma Main Business Overview
13.13.5 Pieris Pharma Latest Developments
13.14 Biosion
13.14.1 Biosion Company Information
13.14.2 Biosion Severe Asthma Treatment Product Portfolios and Specifications
13.14.3 Biosion Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Biosion Main Business Overview
13.14.5 Biosion Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Severe Asthma Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Severe Asthma Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Severe Asthma Treatment by Country/Region, 2018, 2022 & 2029
2.2 Severe Asthma Treatment Segment by Type
2.2.1 Oral
2.2.2 lnhaled
2.2.3 lntravenous
2.2.4 Subcutaneous
2.3 Severe Asthma Treatment Sales by Type
2.3.1 Global Severe Asthma Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Severe Asthma Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Severe Asthma Treatment Sale Price by Type (2018-2023)
2.4 Severe Asthma Treatment Segment by Application
2.4.1 Children
2.4.2 Adults
2.4.3 Teenagers
2.5 Severe Asthma Treatment Sales by Application
2.5.1 Global Severe Asthma Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Severe Asthma Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Severe Asthma Treatment Sale Price by Application (2018-2023)
3 GLOBAL SEVERE ASTHMA TREATMENT BY COMPANY
3.1 Global Severe Asthma Treatment Breakdown Data by Company
3.1.1 Global Severe Asthma Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Severe Asthma Treatment Sales Market Share by Company (2018-2023)
3.2 Global Severe Asthma Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Severe Asthma Treatment Revenue by Company (2018-2023)
3.2.2 Global Severe Asthma Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Severe Asthma Treatment Sale Price by Company
3.4 Key Manufacturers Severe Asthma Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Severe Asthma Treatment Product Location Distribution
3.4.2 Players Severe Asthma Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SEVERE ASTHMA TREATMENT BY GEOGRAPHIC REGION
4.1 World Historic Severe Asthma Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Severe Asthma Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Severe Asthma Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Severe Asthma Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Severe Asthma Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Severe Asthma Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Severe Asthma Treatment Sales Growth
4.4 APAC Severe Asthma Treatment Sales Growth
4.5 Europe Severe Asthma Treatment Sales Growth
4.6 Middle East & Africa Severe Asthma Treatment Sales Growth
5 AMERICAS
5.1 Americas Severe Asthma Treatment Sales by Country
5.1.1 Americas Severe Asthma Treatment Sales by Country (2018-2023)
5.1.2 Americas Severe Asthma Treatment Revenue by Country (2018-2023)
5.2 Americas Severe Asthma Treatment Sales by Type
5.3 Americas Severe Asthma Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Severe Asthma Treatment Sales by Region
6.1.1 APAC Severe Asthma Treatment Sales by Region (2018-2023)
6.1.2 APAC Severe Asthma Treatment Revenue by Region (2018-2023)
6.2 APAC Severe Asthma Treatment Sales by Type
6.3 APAC Severe Asthma Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Severe Asthma Treatment by Country
7.1.1 Europe Severe Asthma Treatment Sales by Country (2018-2023)
7.1.2 Europe Severe Asthma Treatment Revenue by Country (2018-2023)
7.2 Europe Severe Asthma Treatment Sales by Type
7.3 Europe Severe Asthma Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Severe Asthma Treatment by Country
8.1.1 Middle East & Africa Severe Asthma Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Severe Asthma Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Severe Asthma Treatment Sales by Type
8.3 Middle East & Africa Severe Asthma Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Severe Asthma Treatment
10.3 Manufacturing Process Analysis of Severe Asthma Treatment
10.4 Industry Chain Structure of Severe Asthma Treatment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Severe Asthma Treatment Distributors
11.3 Severe Asthma Treatment Customer
12 WORLD FORECAST REVIEW FOR SEVERE ASTHMA TREATMENT BY GEOGRAPHIC REGION
12.1 Global Severe Asthma Treatment Market Size Forecast by Region
12.1.1 Global Severe Asthma Treatment Forecast by Region (2024-2029)
12.1.2 Global Severe Asthma Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Severe Asthma Treatment Forecast by Type
12.7 Global Severe Asthma Treatment Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Teva Pharmaceutical
13.1.1 Teva Pharmaceutical Company Information
13.1.2 Teva Pharmaceutical Severe Asthma Treatment Product Portfolios and Specifications
13.1.3 Teva Pharmaceutical Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Teva Pharmaceutical Main Business Overview
13.1.5 Teva Pharmaceutical Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Severe Asthma Treatment Product Portfolios and Specifications
13.2.3 AstraZeneca Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Severe Asthma Treatment Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Severe Asthma Treatment Product Portfolios and Specifications
13.4.3 Novartis Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Severe Asthma Treatment Product Portfolios and Specifications
13.5.3 Sanofi Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Regeneron Pharmaceutical
13.6.1 Regeneron Pharmaceutical Company Information
13.6.2 Regeneron Pharmaceutical Severe Asthma Treatment Product Portfolios and Specifications
13.6.3 Regeneron Pharmaceutical Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Regeneron Pharmaceutical Main Business Overview
13.6.5 Regeneron Pharmaceutical Latest Developments
13.7 4D Pharma plc
13.7.1 4D Pharma plc Company Information
13.7.2 4D Pharma plc Severe Asthma Treatment Product Portfolios and Specifications
13.7.3 4D Pharma plc Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 4D Pharma plc Main Business Overview
13.7.5 4D Pharma plc Latest Developments
13.8 AB Pharma
13.8.1 AB Pharma Company Information
13.8.2 AB Pharma Severe Asthma Treatment Product Portfolios and Specifications
13.8.3 AB Pharma Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 AB Pharma Main Business Overview
13.8.5 AB Pharma Latest Developments
13.9 Morphosys
13.9.1 Morphosys Company Information
13.9.2 Morphosys Severe Asthma Treatment Product Portfolios and Specifications
13.9.3 Morphosys Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Morphosys Main Business Overview
13.9.5 Morphosys Latest Developments
13.10 Roche
13.10.1 Roche Company Information
13.10.2 Roche Severe Asthma Treatment Product Portfolios and Specifications
13.10.3 Roche Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Roche Main Business Overview
13.10.5 Roche Latest Developments
13.11 Avalo Therapeutics
13.11.1 Avalo Therapeutics Company Information
13.11.2 Avalo Therapeutics Severe Asthma Treatment Product Portfolios and Specifications
13.11.3 Avalo Therapeutics Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Avalo Therapeutics Main Business Overview
13.11.5 Avalo Therapeutics Latest Developments
13.12 Suzhou Connect Biopharmaceuticals
13.12.1 Suzhou Connect Biopharmaceuticals Company Information
13.12.2 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product Portfolios and Specifications
13.12.3 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Suzhou Connect Biopharmaceuticals Main Business Overview
13.12.5 Suzhou Connect Biopharmaceuticals Latest Developments
13.13 Pieris Pharma
13.13.1 Pieris Pharma Company Information
13.13.2 Pieris Pharma Severe Asthma Treatment Product Portfolios and Specifications
13.13.3 Pieris Pharma Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Pieris Pharma Main Business Overview
13.13.5 Pieris Pharma Latest Developments
13.14 Biosion
13.14.1 Biosion Company Information
13.14.2 Biosion Severe Asthma Treatment Product Portfolios and Specifications
13.14.3 Biosion Severe Asthma Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Biosion Main Business Overview
13.14.5 Biosion Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Severe Asthma Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Severe Asthma Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of lnhaled
Table 5. Major Players of lntravenous
Table 6. Major Players of Subcutaneous
Table 7. Global Severe Asthma Treatment Sales by Type (2018-2023) & (K Units)
Table 8. Global Severe Asthma Treatment Sales Market Share by Type (2018-2023)
Table 9. Global Severe Asthma Treatment Revenue by Type (2018-2023) & ($ million)
Table 10. Global Severe Asthma Treatment Revenue Market Share by Type (2018-2023)
Table 11. Global Severe Asthma Treatment Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Severe Asthma Treatment Sales by Application (2018-2023) & (K Units)
Table 13. Global Severe Asthma Treatment Sales Market Share by Application (2018-2023)
Table 14. Global Severe Asthma Treatment Revenue by Application (2018-2023)
Table 15. Global Severe Asthma Treatment Revenue Market Share by Application (2018-2023)
Table 16. Global Severe Asthma Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Severe Asthma Treatment Sales by Company (2018-2023) & (K Units)
Table 18. Global Severe Asthma Treatment Sales Market Share by Company (2018-2023)
Table 19. Global Severe Asthma Treatment Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Severe Asthma Treatment Revenue Market Share by Company (2018-2023)
Table 21. Global Severe Asthma Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Severe Asthma Treatment Producing Area Distribution and Sales Area
Table 23. Players Severe Asthma Treatment Products Offered
Table 24. Severe Asthma Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Severe Asthma Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Severe Asthma Treatment Sales Market Share Geographic Region (2018-2023)
Table 29. Global Severe Asthma Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Severe Asthma Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Severe Asthma Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Severe Asthma Treatment Sales Market Share by Country/Region (2018-2023)
Table 33. Global Severe Asthma Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Severe Asthma Treatment Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Severe Asthma Treatment Sales by Country (2018-2023) & (K Units)
Table 36. Americas Severe Asthma Treatment Sales Market Share by Country (2018-2023)
Table 37. Americas Severe Asthma Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Severe Asthma Treatment Revenue Market Share by Country (2018-2023)
Table 39. Americas Severe Asthma Treatment Sales by Type (2018-2023) & (K Units)
Table 40. Americas Severe Asthma Treatment Sales by Application (2018-2023) & (K Units)
Table 41. APAC Severe Asthma Treatment Sales by Region (2018-2023) & (K Units)
Table 42. APAC Severe Asthma Treatment Sales Market Share by Region (2018-2023)
Table 43. APAC Severe Asthma Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Severe Asthma Treatment Revenue Market Share by Region (2018-2023)
Table 45. APAC Severe Asthma Treatment Sales by Type (2018-2023) & (K Units)
Table 46. APAC Severe Asthma Treatment Sales by Application (2018-2023) & (K Units)
Table 47. Europe Severe Asthma Treatment Sales by Country (2018-2023) & (K Units)
Table 48. Europe Severe Asthma Treatment Sales Market Share by Country (2018-2023)
Table 49. Europe Severe Asthma Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Severe Asthma Treatment Revenue Market Share by Country (2018-2023)
Table 51. Europe Severe Asthma Treatment Sales by Type (2018-2023) & (K Units)
Table 52. Europe Severe Asthma Treatment Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Severe Asthma Treatment Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Severe Asthma Treatment Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Severe Asthma Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Severe Asthma Treatment Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Severe Asthma Treatment Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Severe Asthma Treatment Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Severe Asthma Treatment
Table 60. Key Market Challenges & Risks of Severe Asthma Treatment
Table 61. Key Industry Trends of Severe Asthma Treatment
Table 62. Severe Asthma Treatment Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Severe Asthma Treatment Distributors List
Table 65. Severe Asthma Treatment Customer List
Table 66. Global Severe Asthma Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Severe Asthma Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Severe Asthma Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Severe Asthma Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Severe Asthma Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Severe Asthma Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Severe Asthma Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Severe Asthma Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Severe Asthma Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Severe Asthma Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Severe Asthma Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Severe Asthma Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Severe Asthma Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Severe Asthma Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Teva Pharmaceutical Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 81. Teva Pharmaceutical Severe Asthma Treatment Product Portfolios and Specifications
Table 82. Teva Pharmaceutical Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Teva Pharmaceutical Main Business
Table 84. Teva Pharmaceutical Latest Developments
Table 85. AstraZeneca Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 86. AstraZeneca Severe Asthma Treatment Product Portfolios and Specifications
Table 87. AstraZeneca Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. AstraZeneca Main Business
Table 89. AstraZeneca Latest Developments
Table 90. GlaxoSmithKline Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 91. GlaxoSmithKline Severe Asthma Treatment Product Portfolios and Specifications
Table 92. GlaxoSmithKline Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. GlaxoSmithKline Main Business
Table 94. GlaxoSmithKline Latest Developments
Table 95. Novartis Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 96. Novartis Severe Asthma Treatment Product Portfolios and Specifications
Table 97. Novartis Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Novartis Main Business
Table 99. Novartis Latest Developments
Table 100. Sanofi Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 101. Sanofi Severe Asthma Treatment Product Portfolios and Specifications
Table 102. Sanofi Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Sanofi Main Business
Table 104. Sanofi Latest Developments
Table 105. Regeneron Pharmaceutical Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 106. Regeneron Pharmaceutical Severe Asthma Treatment Product Portfolios and Specifications
Table 107. Regeneron Pharmaceutical Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Regeneron Pharmaceutical Main Business
Table 109. Regeneron Pharmaceutical Latest Developments
Table 110. 4D Pharma plc Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 111. 4D Pharma plc Severe Asthma Treatment Product Portfolios and Specifications
Table 112. 4D Pharma plc Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. 4D Pharma plc Main Business
Table 114. 4D Pharma plc Latest Developments
Table 115. AB Pharma Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 116. AB Pharma Severe Asthma Treatment Product Portfolios and Specifications
Table 117. AB Pharma Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. AB Pharma Main Business
Table 119. AB Pharma Latest Developments
Table 120. Morphosys Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 121. Morphosys Severe Asthma Treatment Product Portfolios and Specifications
Table 122. Morphosys Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Morphosys Main Business
Table 124. Morphosys Latest Developments
Table 125. Roche Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 126. Roche Severe Asthma Treatment Product Portfolios and Specifications
Table 127. Roche Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Roche Main Business
Table 129. Roche Latest Developments
Table 130. Avalo Therapeutics Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 131. Avalo Therapeutics Severe Asthma Treatment Product Portfolios and Specifications
Table 132. Avalo Therapeutics Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Avalo Therapeutics Main Business
Table 134. Avalo Therapeutics Latest Developments
Table 135. Suzhou Connect Biopharmaceuticals Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 136. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product Portfolios and Specifications
Table 137. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Suzhou Connect Biopharmaceuticals Main Business
Table 139. Suzhou Connect Biopharmaceuticals Latest Developments
Table 140. Pieris Pharma Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 141. Pieris Pharma Severe Asthma Treatment Product Portfolios and Specifications
Table 142. Pieris Pharma Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Pieris Pharma Main Business
Table 144. Pieris Pharma Latest Developments
Table 145. Biosion Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 146. Biosion Severe Asthma Treatment Product Portfolios and Specifications
Table 147. Biosion Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Biosion Main Business
Table 149. Biosion Latest Developments
Table 1. Severe Asthma Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Severe Asthma Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of lnhaled
Table 5. Major Players of lntravenous
Table 6. Major Players of Subcutaneous
Table 7. Global Severe Asthma Treatment Sales by Type (2018-2023) & (K Units)
Table 8. Global Severe Asthma Treatment Sales Market Share by Type (2018-2023)
Table 9. Global Severe Asthma Treatment Revenue by Type (2018-2023) & ($ million)
Table 10. Global Severe Asthma Treatment Revenue Market Share by Type (2018-2023)
Table 11. Global Severe Asthma Treatment Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Severe Asthma Treatment Sales by Application (2018-2023) & (K Units)
Table 13. Global Severe Asthma Treatment Sales Market Share by Application (2018-2023)
Table 14. Global Severe Asthma Treatment Revenue by Application (2018-2023)
Table 15. Global Severe Asthma Treatment Revenue Market Share by Application (2018-2023)
Table 16. Global Severe Asthma Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Severe Asthma Treatment Sales by Company (2018-2023) & (K Units)
Table 18. Global Severe Asthma Treatment Sales Market Share by Company (2018-2023)
Table 19. Global Severe Asthma Treatment Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Severe Asthma Treatment Revenue Market Share by Company (2018-2023)
Table 21. Global Severe Asthma Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Severe Asthma Treatment Producing Area Distribution and Sales Area
Table 23. Players Severe Asthma Treatment Products Offered
Table 24. Severe Asthma Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Severe Asthma Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Severe Asthma Treatment Sales Market Share Geographic Region (2018-2023)
Table 29. Global Severe Asthma Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Severe Asthma Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Severe Asthma Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Severe Asthma Treatment Sales Market Share by Country/Region (2018-2023)
Table 33. Global Severe Asthma Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Severe Asthma Treatment Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Severe Asthma Treatment Sales by Country (2018-2023) & (K Units)
Table 36. Americas Severe Asthma Treatment Sales Market Share by Country (2018-2023)
Table 37. Americas Severe Asthma Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Severe Asthma Treatment Revenue Market Share by Country (2018-2023)
Table 39. Americas Severe Asthma Treatment Sales by Type (2018-2023) & (K Units)
Table 40. Americas Severe Asthma Treatment Sales by Application (2018-2023) & (K Units)
Table 41. APAC Severe Asthma Treatment Sales by Region (2018-2023) & (K Units)
Table 42. APAC Severe Asthma Treatment Sales Market Share by Region (2018-2023)
Table 43. APAC Severe Asthma Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Severe Asthma Treatment Revenue Market Share by Region (2018-2023)
Table 45. APAC Severe Asthma Treatment Sales by Type (2018-2023) & (K Units)
Table 46. APAC Severe Asthma Treatment Sales by Application (2018-2023) & (K Units)
Table 47. Europe Severe Asthma Treatment Sales by Country (2018-2023) & (K Units)
Table 48. Europe Severe Asthma Treatment Sales Market Share by Country (2018-2023)
Table 49. Europe Severe Asthma Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Severe Asthma Treatment Revenue Market Share by Country (2018-2023)
Table 51. Europe Severe Asthma Treatment Sales by Type (2018-2023) & (K Units)
Table 52. Europe Severe Asthma Treatment Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Severe Asthma Treatment Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Severe Asthma Treatment Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Severe Asthma Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Severe Asthma Treatment Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Severe Asthma Treatment Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Severe Asthma Treatment Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Severe Asthma Treatment
Table 60. Key Market Challenges & Risks of Severe Asthma Treatment
Table 61. Key Industry Trends of Severe Asthma Treatment
Table 62. Severe Asthma Treatment Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Severe Asthma Treatment Distributors List
Table 65. Severe Asthma Treatment Customer List
Table 66. Global Severe Asthma Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Severe Asthma Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Severe Asthma Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Severe Asthma Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Severe Asthma Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Severe Asthma Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Severe Asthma Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Severe Asthma Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Severe Asthma Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Severe Asthma Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Severe Asthma Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Severe Asthma Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Severe Asthma Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Severe Asthma Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Teva Pharmaceutical Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 81. Teva Pharmaceutical Severe Asthma Treatment Product Portfolios and Specifications
Table 82. Teva Pharmaceutical Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Teva Pharmaceutical Main Business
Table 84. Teva Pharmaceutical Latest Developments
Table 85. AstraZeneca Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 86. AstraZeneca Severe Asthma Treatment Product Portfolios and Specifications
Table 87. AstraZeneca Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. AstraZeneca Main Business
Table 89. AstraZeneca Latest Developments
Table 90. GlaxoSmithKline Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 91. GlaxoSmithKline Severe Asthma Treatment Product Portfolios and Specifications
Table 92. GlaxoSmithKline Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. GlaxoSmithKline Main Business
Table 94. GlaxoSmithKline Latest Developments
Table 95. Novartis Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 96. Novartis Severe Asthma Treatment Product Portfolios and Specifications
Table 97. Novartis Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Novartis Main Business
Table 99. Novartis Latest Developments
Table 100. Sanofi Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 101. Sanofi Severe Asthma Treatment Product Portfolios and Specifications
Table 102. Sanofi Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Sanofi Main Business
Table 104. Sanofi Latest Developments
Table 105. Regeneron Pharmaceutical Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 106. Regeneron Pharmaceutical Severe Asthma Treatment Product Portfolios and Specifications
Table 107. Regeneron Pharmaceutical Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Regeneron Pharmaceutical Main Business
Table 109. Regeneron Pharmaceutical Latest Developments
Table 110. 4D Pharma plc Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 111. 4D Pharma plc Severe Asthma Treatment Product Portfolios and Specifications
Table 112. 4D Pharma plc Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. 4D Pharma plc Main Business
Table 114. 4D Pharma plc Latest Developments
Table 115. AB Pharma Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 116. AB Pharma Severe Asthma Treatment Product Portfolios and Specifications
Table 117. AB Pharma Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. AB Pharma Main Business
Table 119. AB Pharma Latest Developments
Table 120. Morphosys Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 121. Morphosys Severe Asthma Treatment Product Portfolios and Specifications
Table 122. Morphosys Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Morphosys Main Business
Table 124. Morphosys Latest Developments
Table 125. Roche Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 126. Roche Severe Asthma Treatment Product Portfolios and Specifications
Table 127. Roche Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Roche Main Business
Table 129. Roche Latest Developments
Table 130. Avalo Therapeutics Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 131. Avalo Therapeutics Severe Asthma Treatment Product Portfolios and Specifications
Table 132. Avalo Therapeutics Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Avalo Therapeutics Main Business
Table 134. Avalo Therapeutics Latest Developments
Table 135. Suzhou Connect Biopharmaceuticals Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 136. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product Portfolios and Specifications
Table 137. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Suzhou Connect Biopharmaceuticals Main Business
Table 139. Suzhou Connect Biopharmaceuticals Latest Developments
Table 140. Pieris Pharma Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 141. Pieris Pharma Severe Asthma Treatment Product Portfolios and Specifications
Table 142. Pieris Pharma Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Pieris Pharma Main Business
Table 144. Pieris Pharma Latest Developments
Table 145. Biosion Basic Information, Severe Asthma Treatment Manufacturing Base, Sales Area and Its Competitors
Table 146. Biosion Severe Asthma Treatment Product Portfolios and Specifications
Table 147. Biosion Severe Asthma Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Biosion Main Business
Table 149. Biosion Latest Developments
LIST OF FIGURES
Figure 1. Picture of Severe Asthma Treatment
Figure 2. Severe Asthma Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Severe Asthma Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Severe Asthma Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Severe Asthma Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of lnhaled
Figure 11. Product Picture of lntravenous
Figure 12. Product Picture of Subcutaneous
Figure 13. Global Severe Asthma Treatment Sales Market Share by Type in 2022
Figure 14. Global Severe Asthma Treatment Revenue Market Share by Type (2018-2023)
Figure 15. Severe Asthma Treatment Consumed in Children
Figure 16. Global Severe Asthma Treatment Market: Children (2018-2023) & (K Units)
Figure 17. Severe Asthma Treatment Consumed in Adults
Figure 18. Global Severe Asthma Treatment Market: Adults (2018-2023) & (K Units)
Figure 19. Severe Asthma Treatment Consumed in Teenagers
Figure 20. Global Severe Asthma Treatment Market: Teenagers (2018-2023) & (K Units)
Figure 21. Global Severe Asthma Treatment Sales Market Share by Application (2022)
Figure 22. Global Severe Asthma Treatment Revenue Market Share by Application in 2022
Figure 23. Severe Asthma Treatment Sales Market by Company in 2022 (K Units)
Figure 24. Global Severe Asthma Treatment Sales Market Share by Company in 2022
Figure 25. Severe Asthma Treatment Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Severe Asthma Treatment Revenue Market Share by Company in 2022
Figure 27. Global Severe Asthma Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Severe Asthma Treatment Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Severe Asthma Treatment Sales 2018-2023 (K Units)
Figure 30. Americas Severe Asthma Treatment Revenue 2018-2023 ($ Millions)
Figure 31. APAC Severe Asthma Treatment Sales 2018-2023 (K Units)
Figure 32. APAC Severe Asthma Treatment Revenue 2018-2023 ($ Millions)
Figure 33. Europe Severe Asthma Treatment Sales 2018-2023 (K Units)
Figure 34. Europe Severe Asthma Treatment Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Severe Asthma Treatment Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Severe Asthma Treatment Revenue 2018-2023 ($ Millions)
Figure 37. Americas Severe Asthma Treatment Sales Market Share by Country in 2022
Figure 38. Americas Severe Asthma Treatment Revenue Market Share by Country in 2022
Figure 39. Americas Severe Asthma Treatment Sales Market Share by Type (2018-2023)
Figure 40. Americas Severe Asthma Treatment Sales Market Share by Application (2018-2023)
Figure 41. United States Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Severe Asthma Treatment Sales Market Share by Region in 2022
Figure 46. APAC Severe Asthma Treatment Revenue Market Share by Regions in 2022
Figure 47. APAC Severe Asthma Treatment Sales Market Share by Type (2018-2023)
Figure 48. APAC Severe Asthma Treatment Sales Market Share by Application (2018-2023)
Figure 49. China Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Severe Asthma Treatment Sales Market Share by Country in 2022
Figure 57. Europe Severe Asthma Treatment Revenue Market Share by Country in 2022
Figure 58. Europe Severe Asthma Treatment Sales Market Share by Type (2018-2023)
Figure 59. Europe Severe Asthma Treatment Sales Market Share by Application (2018-2023)
Figure 60. Germany Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Severe Asthma Treatment Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Severe Asthma Treatment Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Severe Asthma Treatment Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Severe Asthma Treatment Sales Market Share by Application (2018-2023)
Figure 69. Egypt Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Severe Asthma Treatment in 2022
Figure 75. Manufacturing Process Analysis of Severe Asthma Treatment
Figure 76. Industry Chain Structure of Severe Asthma Treatment
Figure 77. Channels of Distribution
Figure 78. Global Severe Asthma Treatment Sales Market Forecast by Region (2024-2029)
Figure 79. Global Severe Asthma Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Severe Asthma Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Severe Asthma Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Severe Asthma Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Severe Asthma Treatment Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Severe Asthma Treatment
Figure 2. Severe Asthma Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Severe Asthma Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Severe Asthma Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Severe Asthma Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of lnhaled
Figure 11. Product Picture of lntravenous
Figure 12. Product Picture of Subcutaneous
Figure 13. Global Severe Asthma Treatment Sales Market Share by Type in 2022
Figure 14. Global Severe Asthma Treatment Revenue Market Share by Type (2018-2023)
Figure 15. Severe Asthma Treatment Consumed in Children
Figure 16. Global Severe Asthma Treatment Market: Children (2018-2023) & (K Units)
Figure 17. Severe Asthma Treatment Consumed in Adults
Figure 18. Global Severe Asthma Treatment Market: Adults (2018-2023) & (K Units)
Figure 19. Severe Asthma Treatment Consumed in Teenagers
Figure 20. Global Severe Asthma Treatment Market: Teenagers (2018-2023) & (K Units)
Figure 21. Global Severe Asthma Treatment Sales Market Share by Application (2022)
Figure 22. Global Severe Asthma Treatment Revenue Market Share by Application in 2022
Figure 23. Severe Asthma Treatment Sales Market by Company in 2022 (K Units)
Figure 24. Global Severe Asthma Treatment Sales Market Share by Company in 2022
Figure 25. Severe Asthma Treatment Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Severe Asthma Treatment Revenue Market Share by Company in 2022
Figure 27. Global Severe Asthma Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Severe Asthma Treatment Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Severe Asthma Treatment Sales 2018-2023 (K Units)
Figure 30. Americas Severe Asthma Treatment Revenue 2018-2023 ($ Millions)
Figure 31. APAC Severe Asthma Treatment Sales 2018-2023 (K Units)
Figure 32. APAC Severe Asthma Treatment Revenue 2018-2023 ($ Millions)
Figure 33. Europe Severe Asthma Treatment Sales 2018-2023 (K Units)
Figure 34. Europe Severe Asthma Treatment Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Severe Asthma Treatment Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Severe Asthma Treatment Revenue 2018-2023 ($ Millions)
Figure 37. Americas Severe Asthma Treatment Sales Market Share by Country in 2022
Figure 38. Americas Severe Asthma Treatment Revenue Market Share by Country in 2022
Figure 39. Americas Severe Asthma Treatment Sales Market Share by Type (2018-2023)
Figure 40. Americas Severe Asthma Treatment Sales Market Share by Application (2018-2023)
Figure 41. United States Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Severe Asthma Treatment Sales Market Share by Region in 2022
Figure 46. APAC Severe Asthma Treatment Revenue Market Share by Regions in 2022
Figure 47. APAC Severe Asthma Treatment Sales Market Share by Type (2018-2023)
Figure 48. APAC Severe Asthma Treatment Sales Market Share by Application (2018-2023)
Figure 49. China Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Severe Asthma Treatment Sales Market Share by Country in 2022
Figure 57. Europe Severe Asthma Treatment Revenue Market Share by Country in 2022
Figure 58. Europe Severe Asthma Treatment Sales Market Share by Type (2018-2023)
Figure 59. Europe Severe Asthma Treatment Sales Market Share by Application (2018-2023)
Figure 60. Germany Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Severe Asthma Treatment Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Severe Asthma Treatment Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Severe Asthma Treatment Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Severe Asthma Treatment Sales Market Share by Application (2018-2023)
Figure 69. Egypt Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Severe Asthma Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Severe Asthma Treatment in 2022
Figure 75. Manufacturing Process Analysis of Severe Asthma Treatment
Figure 76. Industry Chain Structure of Severe Asthma Treatment
Figure 77. Channels of Distribution
Figure 78. Global Severe Asthma Treatment Sales Market Forecast by Region (2024-2029)
Figure 79. Global Severe Asthma Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Severe Asthma Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Severe Asthma Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Severe Asthma Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Severe Asthma Treatment Revenue Market Share Forecast by Application (2024-2029)
